Current and historical daily PE Ratio for Sysmex Corp (
) from 2010 to Jun 17 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sysmex stock (SSMXF) PE ratio as of Jun 17 2024 is 31.89.
More Details
Sysmex Corp (SSMXF) PE Ratio (TTM) Chart
Sysmex Corp (SSMXF) PE Ratio (TTM) Historical Data
View and export this data going back to 2010. Start your Free Trial
Total 1249
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Sysmex PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-17 | 31.9 | 2024-04-12 | 29.5 |
2024-06-14 | 31.9 | 2024-04-11 | 29.5 |
2024-06-13 | 31.9 | 2024-04-10 | 30.5 |
2024-06-12 | 31.9 | 2024-04-09 | 34.2 |
2024-06-11 | 31.9 | 2024-04-08 | 34.2 |
2024-06-10 | 31.9 | 2024-04-05 | 34.2 |
2024-06-07 | 31.9 | 2024-04-04 | 34.2 |
2024-06-06 | 31.9 | 2024-04-03 | 34.2 |
2024-06-05 | 31.9 | 2024-04-02 | 34.2 |
2024-06-04 | 31.9 | 2024-04-01 | 34.2 |
2024-06-03 | 31.9 | 2024-03-28 | 34.2 |
2024-05-31 | 31.9 | 2024-03-27 | 36.7 |
2024-05-30 | 31.9 | 2024-03-26 | 36.7 |
2024-05-29 | 31.9 | 2024-03-25 | 36.7 |
2024-05-28 | 31.9 | 2024-03-22 | 36.7 |
2024-05-24 | 31.9 | 2024-03-21 | 36.7 |
2024-05-23 | 31.9 | 2024-03-20 | 38.9 |
2024-05-22 | 31.9 | 2024-03-19 | 38.9 |
2024-05-21 | 31.9 | 2024-03-18 | 38.9 |
2024-05-20 | 32.4 | 2024-03-15 | 38.9 |
2024-05-17 | 31.7 | 2024-03-14 | 38.9 |
2024-05-16 | 31.7 | 2024-03-13 | 38.9 |
2024-05-15 | 31.7 | 2024-03-12 | 38.9 |
2024-05-14 | 31.7 | 2024-03-11 | 38.9 |
2024-05-13 | 31.7 | 2024-03-08 | 38.9 |
2024-05-10 | 31.7 | 2024-03-07 | 38.9 |
2024-05-09 | 31.7 | 2024-03-06 | 38.9 |
2024-05-08 | 31.7 | 2024-03-05 | 38.9 |
2024-05-07 | 31.7 | 2024-03-04 | 38.9 |
2024-05-06 | 31.7 | 2024-03-01 | 38.9 |
2024-05-03 | 31.7 | 2024-02-29 | 38.9 |
2024-05-02 | 29.5 | 2024-02-28 | 38.9 |
2024-05-01 | 29.5 | 2024-02-27 | 38.9 |
2024-04-30 | 29.5 | 2024-02-26 | 38.9 |
2024-04-29 | 29.5 | 2024-02-23 | 38.9 |
2024-04-26 | 29.5 | 2024-02-22 | 38.9 |
2024-04-25 | 29.5 | 2024-02-21 | 38.9 |
2024-04-24 | 29.5 | 2024-02-20 | 38.9 |
2024-04-23 | 29.5 | 2024-02-16 | 38.9 |
2024-04-22 | 29.5 | 2024-02-15 | 38.9 |
2024-04-19 | 29.5 | 2024-02-14 | 38.9 |
2024-04-18 | 29.5 | 2024-02-13 | 38.9 |
2024-04-17 | 29.5 | 2024-02-12 | 38.9 |
2024-04-16 | 29.5 | 2024-02-09 | 38.9 |
2024-04-15 | 29.5 | 2024-02-08 | 38.9 |
Sysmex Corp (SSMXF) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
![Sysmex Corp Sysmex Corp logo](https://static.gurufocus.com/logos/0C00002C2G.png?14)
Sysmex Corp
NAICS : 339112
ISIN : JP3351100007
Description
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.